tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AKTS Stock Latest News

3 Best Stocks to Buy Today, 3/9/2026, According to Top Analysts
Market News3 Best Stocks to Buy Today, 3/9/2026, According to Top Analysts
1d ago
MWH
AKTS
Aktis Oncology initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Aktis Oncology initiated with a Buy at H.C. Wainwright
1d ago
AKTS
Aktis Oncology’s NECTINIUM-2 Trial: A New Radiopharma Bet in Solid Tumors
PremiumCompany Announcements
Aktis Oncology’s NECTINIUM-2 Trial: A New Radiopharma Bet in Solid Tumors
6d ago
AKTS
Aktis Oncology: Fast-Track Momentum and Pipeline Catalysts Underpin Buy Rating and $34 Price Target
PremiumRatings
Aktis Oncology: Fast-Track Momentum and Pipeline Catalysts Underpin Buy Rating and $34 Price Target
13d ago
AKTS
Aktis Oncology receives U.S. FDA Fast Track Designation for AKY-1189
PremiumThe Fly
Aktis Oncology receives U.S. FDA Fast Track Designation for AKY-1189
14d ago
AKTS
Adobe downgraded, Palantir upgraded: Wall Street’s top analyst calls
PremiumThe FlyAdobe downgraded, Palantir upgraded: Wall Street’s top analyst calls
1M ago
V
MA
Aktis Oncology initiated with an Outperform at Leerink
Premium
The Fly
Aktis Oncology initiated with an Outperform at Leerink
1M ago
AKTS
Aktis Oncology initiated with a Buy at BofA
Premium
The Fly
Aktis Oncology initiated with a Buy at BofA
1M ago
AKTS
Aktis Oncology: Differentiated Miniprotein Radiopharma Platform Underpins Buy Rating and Multi-Billion Dollar Sales Potential
PremiumRatings
Aktis Oncology: Differentiated Miniprotein Radiopharma Platform Underpins Buy Rating and Multi-Billion Dollar Sales Potential
1M ago
AKTS
Aktis Oncology initiated with a Buy at TD Cowen
PremiumThe Fly
Aktis Oncology initiated with a Buy at TD Cowen
1M ago
AKTS
Aktis Oncology initiated with an Overweight at JPMorgan
PremiumThe Fly
Aktis Oncology initiated with an Overweight at JPMorgan
1M ago
AKTS
Opening Day: Aktis Oncology raises $318M in 2026’s first biotech IPO
PremiumThe Fly
Opening Day: Aktis Oncology raises $318M in 2026’s first biotech IPO
2M ago
AKTS
ANDG
Six new option listings and two option delistings on December 18th
PremiumThe FlySix new option listings and two option delistings on December 18th
1y ago
AKTS
BWAY
Akoustis Technologies Initiates Bankruptcy for Strategic Asset Sale
Premium
Company Announcements
Akoustis Technologies Initiates Bankruptcy for Strategic Asset Sale
1y ago
8K
AKTS
Akoustis to pursue sale through chapter 11 process
Premium
The Fly
Akoustis to pursue sale through chapter 11 process
1y ago
AKTS
QRVO
Akoustis Technologies Reports Improved Revenue Amid Legal Challenges
PremiumCompany Announcements
Akoustis Technologies Reports Improved Revenue Amid Legal Challenges
1y ago
AKTS
Akoustis Technologies Names Kamran Cheema CEO and Director
PremiumCompany Announcements
Akoustis Technologies Names Kamran Cheema CEO and Director
1y ago
8K
AKTS
AKTS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
AKTS Earnings this Week: How Will it Perform?
2y ago
AKTS
Akoustis receives an additional purchase order for $13M XBAW filters
PremiumThe Fly
Akoustis receives an additional purchase order for $13M XBAW filters
2y ago
AKTS
Akoustis Technologies Overhauls Leadership and Board
PremiumCompany AnnouncementsAkoustis Technologies Overhauls Leadership and Board
2y ago
8K
AKTS
Akoustis announces resignation of CEO Shealy, appoints Cheerma as interim CEO
Premium
The Fly
Akoustis announces resignation of CEO Shealy, appoints Cheerma as interim CEO
2y ago
AKTS
Akoustis Technologies Announces Executive Leadership Changes
Premium
Company Announcements
Akoustis Technologies Announces Executive Leadership Changes
2y ago
8K
AKTS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >